缺少SMARCA4/BRG1的NSCLC:一个案例报告和文献综述
He Zhang1, Xiong-Wen Tu1, Yu-Qing Wei1
1Department of Respiratory and Critical Care Medicine, Yijishan Hospital, The first Affiliated Hospital of Wannan Medical College, Wuhu, China.
JPMA. The Journal of the Pakistan Medical Association
|November 17, 2025
概括
这项案例研究突出了SMARCA4缺乏症非小细胞肺癌 (NSCLC) 患者有前途的综合治疗方法. 这种方法维持了患者的生活质量,并防止了疾病的进展,为这个具有挑战性的小组提供了希望.
科学领域:
- 在瘤学瘤学.
- 医学案例研究 医学案例研究
- 癌症研究 癌症研究
背景情况:
- 患有SMARCA4缺乏症的非小细胞肺癌 (NSCLC) 患者经常出现晚期疾病和不良预后.
- 目前的治疗方法,包括免疫检查点抑制剂 (ICI) 和化疗,在这个特定的患者群体中显示出低于最佳的疗效.
研究的目的:
- 报告SMARCA4缺陷NSCLC患者成功进行综合治疗的案例.
- 为了说明一种潜在的治疗策略,以改善这一具有挑战性的患者群体的治疗结果.
主要方法:
- 仅有一名SMARCA4缺乏NSCLC的患者使用综合治疗方法进行治疗.
- 干预后对治疗细节和患者的结果进行了监测.
主要成果:
- 患者表现出令人满意的一般状况和改善的生活质量 (QOL).
- 在综合治疗方案后没有观察到疾病进展.
- 治疗耐受性很好,这表明了有利的安全性.
结论:
- 综合性治疗策略可能为管理SMARCA4缺陷NSCLC提供一个可行的选择.
- 需要进一步的研究来探索这种治疗方法在更广泛的患者队列中的有效性和适用性.
- 这一案例强调了需要基于SMARCA4缺乏症等分子特征的NSCLC个性化治疗方法.
相关概念视频
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
The Retinoblastoma Gene
3.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K


